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ABSTRACT Synthetic ochre and amber tRNA suppressor
genes derived from the yeast tRNAmA sequence have been
constructed. They were efficiently transcribed in vitro and
expressed in vivo via a synthetic expression cassette. tRNAUeA
and tRNAI AAVS (IVS = intervening sequence) are relatively
inefficient ochre suppressors. They are toxic to the cell when
expressed on a multicopy plasmid, and they do not suppress at
all when present as single copies. The intron does not seem to
have any effect on suppression. In contrast, the amber sup-
pressor tRNAC!AIVS is efficient when expressed from a
single-copy plasmid, while its efficiency is reduced on a
multicopy vector.
Suppressor tRNAs are useful genetic tools in investigating
the nature of suppressible mutations as well as the transla-
tional process. They also provide a very powerful tool for the
analysis of structure-function relationships in proteins by
allowing defined amino acid substitutions at specified posi-
tions. Unfortunately, only a limited set of suppressors can be
generated by conventional mutagenesis because (i) most
tRNA genes would require two or three changes to be
converted to suppressor tRNA-encoding genes, and (ii)
although a number oftRNA genes are known to be redundant
in the cell, the replacement of a wild-type tRNA gene by its
suppressor counterpart could be deleterious to the cell. This
is likely the case in Saccharomyces cerevisiae, where only
three classes of suppressor tRNAs have been uncovered,
leading to insertion of tyrosine, serine, and leucine (1). Other
suppressors that theoretically could be obtained by a single
base change from the tRNAs leading-to insertion of gluta-
mine, glutamic acid, lysine, or tryptophan have not been
observed. Moreover, it has been shown that a serine-
inserting ochre suppressor is lethal in haploids, while the
diploids that bear one intact copy of the corresponding
tRNASer gene are viable (2, 3).
tRNA genes now can be easily synthesized chemically.
Therefore, one straightforward way of generating new sup-
pressors is to synthesize them de novo. Such an approach has
been shown to be successful in Escherichia coli, where a
large collection of suppressor tRNAs has been obtained (ref.
4; also J.-M.M., J. Normanly, L. G. Kleina, J.A., and
J.H.M., unpublished data); therefore, we decided to extend
this strategy to yeast.
The first suppressors we synthesized are derived from
tRNArJI (Fig. 1). The tRNAPbC sequence has been deter-
mined at the RNA and DNA levels (6-8), and its structure has
been resolved by x-ray crystallography (9, 10). The tRNAPhC
gene has an intron of 19 base pairs (bp) (8). We synthesized
suppressor tRNA genes with and without the intron. These
synthetic genes were cloned into an expression cassette,
which we designed based on the sequence ofa tRNATYr gene,
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FIG. 1. Structure of the precursor tRNAghAA. Numbering is that
of Nishimura (5). The 18-base intron is delineated by the thick
arrows. Positions of the base modifications are indicated. Abbrevi-
ations: Me, methyl; 2T-0-Me, 2'-0-methyl; D, dihydroxy; and YI,
hypermodified.
SUP4. Expression of these genes was studied in vitro in a
yeast RNA polymerase III system and in vivo by transfor-
mation of the genes into yeast.
MATERIALS AND METHODS
Strains, Plasmids, and Media. E. coli strain MC1061 was
used for transformation and large-scale preparation of the
various plasmids. S. cerevisiae strain AHA75 (trpl, ade2-o,
arg8-o, his4-o, leu2-o, lys2-o, tyrJ-o, ura4-o, where o desig-
nates an ochre mutation) (11) was provided by Maynard
Olson. S. cerevisiae strain S2 (trpl, met8-1-a, tyr7-1-a,
ade3-26-a, where a designates an amber mutation) was
constructed by crossing strain AHA75 with strain SL183-21C
provided by Susan Liebman. E. coli strains were grown on
LB medium with ampicillin as described (12), and S. cere-
visiae strains were grown on yeast extract/peptone/dextrose
medium or drop-out plates of synthetic complete medium
minus one amino acid as described by Sherman et al. (13).
Abbreviation: IVS, intervening sequence.
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Oligonucleotides and Gene Synthesis. The following oligo-
nucleotides were synthesized on an Applied Biosystems
(Foster City, CA) 380A DNA synthesizer:
1,
2,
3,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12,
CGCGGATTTAGCTCAGTTGGGAGAGCGCCAGCCTTTAG;
AAAAAACTTCGGTCAAGTT;
ATCTGGAGGTCCTGTGTTCGATCC;
ATCTGGAGGTCCTGTGTTCGATCC;
ACAGAATTCGCATTTTTTGGTAC;
CAAAAAATGCGAATTCTGTGGATCGAACACAGGAC;
CTCCAGATAACTTGACCGAAGTTTTTTCTAAAGTCT;
GGCGCTCTCCCAACTGAGCTAAATCCGCGAGCT;
CTCCAGCTCTAAAGTCT;
CGCGGATTTAGCTCAGTTGGGAGAGCGCCAGACTCTAG;
CTCCAGATCTAGAGTCT;
CGTATACTCTTTCTTCAACAATTAGAGCTCCCGGGTACCAT;
CGATGGTACCCGGGAGCTCTAATTGTTGAAGAAAGAGTATA.
The oligonucleotides were purified, phosphorylated with
kinase, and hybridized as described (4). The rationale for the
gene synthesis was as follows: oligonucleotides 11 and 12
hybridized together are the expression cassette. The ochre
suppressor gene was constructed from oligonucleotides 1
through 7. Modifications to the original tRNARAIA sequence
were: (i) the anticodon was changed from GAA to TTA and
the complementary intron sequence was changed from TTC
to TAA to keep the base pairing between anticodon and
intervening sequence (IVS); (ii) the 3' transcription termina-
tion signal (a stretch of six thymidine residues) was included
in the tRNA gene oligonucleotide sequence instead of the
expression cassette to avoid the risk of incorrect maturation
ofthe 3' end ofthe tRNA, which could have resulted from the
introduction of a restriction site between the coding sequence
and the termination signal; and (iii) Sac I and Kpn I restriction
sites were created at the extremities of the tRNA gene
sequence.
Omitting oligonucleotides 2 and 6 and replacing them by
single-junction oligonucleotide 8 in the hybridizing reaction
yielded the tRNAfUhUAAIVS gene. The corresponding amber
suppressor tRNAPheAAIVS gene was constructed by hybrid-
izing oligonucleotides 3, 4, 5, 7, 9, and 10.
Cloning, Transformation, and Selection. The 41-bp expres-
sion cassette was introduced at the Cla I site of the multicopy
plasmid YRp7 (14). This site was chosen because it lies
between the -10 and the -35 region of the tetracycline
promoter. Inserts at that site frequently result in a tetracy-
cline-sensitive phenotype. The screening for ampicillin-
resistant tetracycline-sensitive clones yielded plasmids with
the insert in either orientation (YJM2, clockwise).
The synthetic suppressor tRNA genes were constructed
and cloned into the two vectors YJM1 and YJM2 cut with Sac
I and Kpn I. Competent E. coli MC1061 cells were trans-
formed by the calcium chloride method (15). While all
YJM2:Phe (with intron) or YJM2:PheAIVS (without intron)
plasmids conferred both ampicillin and tetracycline resist-
ance, the clones with YJM1:Phe or YJM1:PheAIVS remained
tetracycline sensitive.
The suppressor genes were also cloned in the single-copy
plasmid YJM3, which was constructed by introducing at the
BamHI site of YJM2 a 627-bp SAU3AI-BamHI fragment
from plasmid pJW3 (34) containing the CEN3 sequence. The
sequences of these cloned tRNA genes were determined by
dideoxy sequencing.
The plasmids extracted from the E. coli strain were purified
by using cesium chloride and used to transform S. cerevisiae
as described by Sherman et al. (13).
In Vitro Transcription and Base Modification. In vitro
reactions were performed with a yeast nuclear extract (16)
essentially as described (17, 18). The in vitro synthesized
RNAs were digested with different RNases (19), and the
modified nucleosides were separated by the method of
Saneyoshi et al. (20) as described (19).
In Vivo Suppressor Assays. The efficiency of the suppres-
sors in vivo was assayed by the method of Shaw and Olson
(11). In brief, serial dilutions of cells were plated as 5-,ul
aliquots (107 to 101 cells on selective plates), and the plates
were scored for confluent growth after 5 days at 30'C in the
case of the ochre suppressors or 2 days at 30'C in the case of
the amber suppressors.
RESULTS
Transcription of the tRNAl41A Genes Is Efficient in Vitro.
Transcription of tRNA genes in eukaryotes is accomplished
by RNA polymerase III (21). It is primarily controlled by two
sequences internal to the coding region that are highly
conserved among eukaryotic tRNA genes (22-25). Nonethe-
less, some additional features external to the coding region
have been shown to play an important role in transcription.
These include a series of thymidine residues at the 3'
boundary of the transcription unit and a 5' leader sequence
(26, 27).
To efficiently express the synthetic suppressor tRNA
genes in yeast and ensure correct processing of the tran-
scripts, we added a stretch of six thymidine residues at the 3'
end of the tRNA gene sequences and cloned them in vectors
YJM1 and YJM2 with a short synthetic expression cassette
(Fig. 2). The role of this cassette is to provide a 5' leader
sequence as well as the Sac I and Kpn I cloning sites. Shaw
and Olson (11) have shown that 27-36 bases of the 5' flanking
sequence of the SUP4-o gene are required for optimal
expression of the gene. Therefore, we decided to include in
our expression cassette a sequence of 27 bp derived from the
leader sequence of the SUP4-o gene. A cytosine residue was
added at the 5' end to create a CG cohesive end, and the 3'
end was modified to a Sac I restriction site. Additional
restriction sites were included at the 3' end, allowing this
cassette to be used in other shuttle vectors.
To assess the transcriptional efficiency of the expression
cassette, we analyzed the transcription of our constructs in a
yeast nuclear extract. The level of transcription of the
tRNAPih6A genes on YJM2 did not differ significantly from
that of a Sup53 gene cloned on a 2-gim plasmid (18) (Fig. 3).
The primary transcript was not only produced at the same
level as that of the control gene but also was processed
equally well into pre-tRNA in the case of YJM2:Phe or into
mature tRNA in the case of YJM2:PheoAIVS. In this extract
there was no tRNA splicing activity, so pre-tRNAIuhuA con-
taining the intron remained intact. Contrary to what was
observed for the YJM2 constructs, there was no transcription
from the tRNA genes on the YJM1 plasmids. Thus, in one
orientation (YJM2), there was efficient transcription of the
tRNA gene, whereas in the reverse orientation (YJM1),
transcription was apparently inhibited by the surrounding
sequences.
The Ochre Suppressor Is Relatively Inefficient in Vivo.
Competent S. cerevisiae AHA75 cells were transformed and
selected for their ability to grow without tryptophan. The
transformants were then replicated on the various selective
media and tested for suppression of the six different ochre
mutations of AHA75 (Table 1). Ability to suppress a given
nonsense mutation to the point where confluent growth could
be observed after 4-5 days at 30°C was scored as a "+"
(Table 1).
The pattern of suppression that can be deduced from this
table is very similar but not identical to the one obtained with
the ochre tyrosine suppressor tRNAs (11): his4-o was the best
suppressed mutation; arg8-o, leu2-o, and lys2-o were equally
suppressed to a lesser extent; and tyrl-J was poorly sup-
pressed, as was the case with SUP4-o. The ade2-o mutation,
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FIG. 2. The cloning vector YJM2 and the synthetic suppressor genes. (A) The plasmid YJM2 was constructed by inserting the 41-bp
expression cassette in YRp7 at the Cla I site. C, Cla I; E, EcoRI; K, Kpn I; S, Sac I; X, Xho I; Amp, ampicillin; Tet, tetracycline. (B) The
synthetic suppressor genes were assembled from oligonucleotides 6-8 and cloned between the Sac I and Kpn I sites of YJM2 or YJM3.
which was well suppressed by SUP4-o, was not suppressed
at all with tRNAIh'A. Although the ochre suppressor was
expressed, resulting in the growth of colonies on selective
media, there was clearly a deleterious effect ofthe suppressor
because even cells displaying no ochre suppression grew
poorly on SD medium. On rich medium the YJM2 plasmid
carrying the ochre suppressor was rapidly lost. We conclude
that the ochre suppressor gene is toxic when present on a
multicopy vector.
If the toxicity were indeed due to overproduction of the
suppressor tRNA on a multicopy plasmid, this effect might be
reduced by lowering the number of copies of the tRNAPhe
gene in the cell. This was done by two independent proce-
dures: (i) by selecting for single-copy integration of the
plasmid YJM2:Pheo linearized with Bgl 11 (28), and (ii) by
a b c d
FIG. 3. In vitro transcription of the YJM1 and YJM2 constructs.
Cesium chloride-purified plasmid (100 ng) was transcribed with a
yeast nuclear extract (16) in the presence of [a-32p]UTP. After
extraction with phenol/chloroform and precipitation with ethanol,
the RNA products were separated on an 8% acrylamide/7M urea gel.
Lanes: a, control, YIpLEU2SUP53 (band 1, primary transcript; band
1', end-processed pre-tRNA); b, YJM2:Phe,, (band 2, primary
transcript; band 2', end-processed pre-tRNAIPiYA); c, YJM2:
Phe0,AIVS (band 3, primary transcript; band 3', end-processed
mature tRNAu~hu1A); d, YJM1:Phe., no transcript.
introducing into the plasmid a yeast centromeric sequence
(CEN3) that ensures a copy number of YJM3:Pheo of one to
two per cell (29). In both cases the transformed cell grew on
medium without tryptophan with a growth rate similar to that
of cells transformed with YRp7. However, we found that the
tRNAPheA gene did not suppress at all in single copy, either
integrated in the yeast genome or on a CEN3 vector (Table
1).
The Intron Has no Obvious Effect on Suppression. Two
studies, on SUP6 and SUP53, have shown that deletion ofthe
intron from a tRNA gene results in under modification of the
tRNA with marked effects on the suppressor efficiency (18,
19). As described above, we assembled tRNAPUUA suppres-
sors with and without the intron. Fig. 2 shows that both of
these genes were equally well transcribed. We then compared
the in vitro base modifications of the tRNA products by
transcribing both genes in vitro in the presence of the methyl
donor S-adenosylmethionine (30) and [a-32P]UTP, [a-
32P]ATP, or [a-32P]CTP. The labeled, end-processed RNAs
were digested with RNases T1, T2, and A, producing nucle-
oside 3' monophosphates labeled by nearest-neighbor trans-
fer. Fig. 4 compares the digests obtained with the precursor
and the mature tRNAs in the case of [a-32P]UTP labeling.
Table 1. Suppressor phenotypes of the strains containing the
ochre and amber suppressors
Ochre suppressors Amber suppressors
Strains tyri arg8 ade2 lys2 leu2 his4 met8-1 tyr7-1 ade3-26
YJM2:Phe. + ++ - ++ ++ +++
YJM2:Phe0-
AIVS + ++ - ++ ++ +++
YJM3:Phe.
YJM2:Phea-
AIVS ++++ +++ +++
YJM3:Phea-
AIVS ++ + +
Suppression phenotypes as determined by the test of Shaw and
Olson (11). Serial dilutions of cells in 5-jul aliquots were assayed for
confluent growth on selective media at 30TC after 5 days for the ochre
suppressors (signified by subscript o) because of their low efficiency
or after 2 days for the amber suppressors (signified by subscript a).
In the table the number of cells required to give confluent growth on
a given selective media is depicted as "+" to "+ + ++" (10' cells,
+ to 103 cells, + + + +) or - (no growth at whatever concentration).
CGCGGATTTAGCTCAGTTGGGAGAGCGCCAGACTTTAG.AAAAAACTAAGGTCAAGT7'ATCTGGAGGTCCTGTGTTCGATCdACAGAATTCGCATTTTTTGGT
TCGAGCGCCTAAATCGAGTCAACCCTCTCGCGG.TCTGAAATCTTTTTTGATTCCAGTTCAATAGACCTqCAGGACACAAGCTAGGTGTCTTAAGCGTAAAAAAC
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FIG. 4. Modified nucleotide analysis of tRNAUiUA and
tRNAuhuAAIVS. The end-processed transcript made in vitro in the
presence of a [a-32P]UTP and the methyl donor S-adenosylmeth-
ionine were digested and chromatographed as described (19). The
nucleotide 3'-monophosphates are identified with abbreviations
consistent with those in Fig. 1. 2'-O-Me-CpUp, 2'-O-methylcytosine-
uridine dinucleotide 3' monophosphate (this dinucleotide is not
hydrolyzed by the RNase cocktail).
Among the modified bases that could be resolved clearly with
this system were some common to both patterns (pseudour-
idine-39 and -55 and ribothymidine-54), denoting modifica-
tion enzymes that work on either intron-containing precursor
or intact tRNA. Other modifications were present only on the
mature tRNA (2'-O-methylcytosine-32), while the only mod-
ification that was specific to the pre-tRNA and therefore
required the presence of the intron was the 5-methylation of
cytosine-40 and probably cytosine-48.
In the case ofSUP6 (19) and SUP53 (18), it has been shown
that the presence of the intron was required for the modifi-
cation of bases within the anticodon, these modifications
being important for the efficiency of the suppressors. In
tRNAPhe, there was no such modification of the bases of the
anticodon, and this can probably account for the fact that
when the two constructs were assayed in vivo, no difference
could be seen in the level of their suppression (Table 1). There
was no clear difference in suppressor efficiency between the
gene with an intron and the gene without an intron.
The Synthetic Amber Suppressor Gene Is Efficient in Vivo.
In yeast, the amber suppressors, especially those inserting
tyrosine, are very efficient (1). Replacing oligonucleotides 1
and 8 by oligonucleotides 9 and 10 yielded the intronless
amber suppressor gene tRNAVJIAAIVS. This gene was
cloned into both the YJM2 vector and the YJM3 vector and
was used to transform cells of S. cerevisiae strain S2. The
transformants were selected on SD medium without trypto-
phan and then assayed for the suppression of the three amber
markers, met8-1-a, tyr7-1-a, and ade3-26-a.
The S2 cells bearing the multicopy version of the amber
suppressor gene (YJM2:PheaAIVS) grew at a significantly
slower rate than the ones bearing the single copy of the
suppressor gene (YJM3:PheaAIVS) and lost the plasmid at a
high frequency (95% loss in 72 hr). Nonetheless, the toxicity
ofthe multicopy amber suppressor gene was much lower than
that of its ochre counterpart, and its suppression efficiency
was substantially higher (Table 1). On the other hand, the
presence of YJM3:PheaAIVS did not seem to impede cell
growth because there was no measurable loss of the plasmid
on SD-minus-tryptophan medium, and a strong suppression
effect for all three amber markers was observed (Table 1).
DISCUSSION
We have demonstrated that new suppressors can be gener-
ated in yeast via gene synthesis. The first such suppressors,
derived from the tRNAhAh gene sequence, have been ex-
pressed in vivo through a short synthetic expression cassette.
We find that tRNA~cVAAIVS is an efficient amber suppressor
when expressed on a single-copy plasmid, while its efficiency
is reduced when it is expressed on a multicopy plasmid. In
contrast, the ochre suppressor tRNApuhuAAIVS (or tRNAUIUA)
gene codes for a rather inefficient suppressor and is func-
tional only on a multicopy plasmid, where it is toxic to the
cells. This contrast can be accounted for by a combination of
factors: (i) the high instability of the multicopy plasmids
combined with the toxicity of the suppressors, the toxicity
being enhanced by the high number of copies; (ii) an obvious
difference in intrinsic toxicity; and (iii) a difference in the
intrinsic efficiency between the ochre and the amber sup-
pressors. Such a difference in efficiency between two iso-
genic suppressors has not been encountered before in yeast.
More detailed biochemical studies are needed to determine
whether the cause of this discrepancy lies at the level of the
interaction with the tRNA synthetase or with the ribosome.
A number of yeast nuclear tRNA genes contain an intron,
while others do not. This difference can be found even
between isoacceptors (31). The only important role that has
been assigned to these introns is to ensure correct modifica-
tion of some of the bases of the anticodon loop. These
modified bases are critical to the translational efficiency (32)
or the suppression efficiency (18, 19). The tRNAPhe gene has
an intron of 18 bp that may be required for the methylation
of the cytosine-40 or -48. The only difference in the modifi-
cation pattern between tRNAPUhUA and tRNAPUiAAIVS that
could be detected in the region of the anticodon loop is the
2'-O-methylation of cytosine-32 that is only present on the
mature tRNA. We saw no evidence of modification on the
anticodon bases of the tRNAPhe gene, and this can be related
to the fact that the intron seems to play no role in the
efficiency of this suppressor.
Other synthetic suppressor genes can be expressed in vivo
by using the same multicopy or single-copy vectors, and this
system should ultimately allow one to obtain a larger set of
suppressors in yeast, as has been achieved in E. coli by a
similar strategy (ref. 4; J.-M.M., J. Normanly, L. G. Kleina,
J.A., and J.H.M., unpublished data). Developing such a tool
also requires a more detailed understanding of the rules
governing suppression in yeast. The gene synthesis approach
chosen here provides a convenient system to investigate the
function of yeast suppressors as well as the means of
improving their efficiency by specific base changes. Since
yeast suppressors have been shown to work in other eukary-
otic cells (33), this approach should have widespread signif-
icance.
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